Centers for Disease Control: Pneumocystis pneumonia-Los Angeles. MMWR30:250-252, 1981
2.
Barre-Sinoussi F., Nugeyre M., Dauguet C., et al: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome. Science220:868-871, 1983
3.
Anonymous: Needlestick transmission of HTLV-III from a patient infected in Africa. Lancet2:1376-1377, 1984
4.
Centers for Disease Control: Update: Universal precautions for prevention of transmission of HIV, HBV, and other bloodbome pathogens in health-care settings. MMWR37:377-388, 1988
5.
Masur H.: Problems in the management of opportunistic infections in patients infected with human immunodeficiency virus. J Infect Dis161:858-864, 1990
6.
Pharmaceutical Manufacturers Association: 1991Survey Report: AIDS Medicines in Development. Washington, DC, Pharmaceutical Manufacturers Association , October, 1991
7.
Kapusnik-Uner JE: Risk of exposure to HIV infection for clinical pharmacists. Am J Hosp Pharm46:S14-15, 1989 (suppl 3)
8.
Huffman MD: On being an HIV-positive pharmacist. Am J Hosp Pharm48:148-150,1991
